Rainbow Children’s Medicare to Expand Hospital Network with ₹2,200 Crore Investment

Rainbow Children’s Medicare, a prominent hospital chain based in Hyderabad, announced plans to invest approximately ₹2,200 crore to significantly increase its hospital bed capacity to over 5,000 by the fiscal year 2032. The company intends to finance this expansion solely through its internal accruals, avoiding additional debt or equity funding.

Currently, Rainbow Children’s Medicare operates a network featuring 2,685 beds. By the end of fiscal 2030, the hospital chain aims to raise this number to 3,875 beds. The company is also in negotiations to add another 1,125 beds, potentially pushing the total capacity beyond 5,000 beds by FY32.

Speaking with Business Standard, CEO Abrarali Dalal emphasized that the entire ₹2,000-2,200 crore investment required for this growth will be sourced from internal resources. Dalal confirmed, "Whatever ₹2,000 crore or ₹2,200 crore that we need is absolutely going to happen through internal accruals," further clarifying that the company is not pursuing fresh debt or private equity funding. As of September 2026, Rainbow Children’s Medicare held around ₹540 crore in cash and bank balances.

The expansion involves an average investment ranging from ₹70 lakh to ₹80 lakh per bed, varying with hospital infrastructure and type. This is consistent with the costs typically associated with establishing high-quality healthcare facilities.

The company’s investor presentation for the second quarter of FY27 detailed plans to add 1,190 beds by FY30. This phased addition includes 25 beds in FY27, 385 in FY28, 630 in FY29, and 150 in FY30. Key cities targeted for new hospital projects include Mumbai, Gurugram, Coimbatore, Pune, Indore, Bengaluru, and Amaravati in Andhra Pradesh.

Rainbow Children’s Medicare plans to open a 100-bed hospital in Mumbai in the first quarter of FY28 and is actively considering further expansions in the city. Dalal stated, "Mumbai will surely have more hospitals," indicating ongoing evaluations of potential sites once the new facility begins operations.

In Gurugram, the company is developing two hospitals with a combined capacity of 450 beds: a 325-bed hospital in Sector 44 and a 125-bed hospital in Sector 56. There is also exploration of opportunities in Noida. Dalal noted that the expansion strategy will mainly focus on greenfield and brownfield projects rather than acquisitions, given the limited number of hospital operators with a similar mix of pediatric, maternity, and fertility services.

The growth phase is affecting profitability metrics. During Q2 FY27, Rainbow’s revenue rose 23.2% year-on-year to ₹548 crore, while earnings before interest, tax, depreciation, and amortization (EBITDA) grew by 14.2% to ₹170 crore. However, the EBITDA margin contracted to 31% from 33.5% in the previous year. Overall occupancy dropped to 49.2% from 52%, even as inpatient discharges increased by 15% and outpatient consultations by 19%.

Dalal attributed the margin pressure partly to the new hospitals, which typically take 18 to 24 months to achieve break-even occupancy levels. He explained that occupancy ramp-up varies by market, with Hyderabad showing quicker patient uptake compared to more competitive areas like Bengaluru. The margin impact from new hospital openings is expected to reduce EBITDA margins by approximately 0.5 to 1 percentage point.

The company aims for a blended occupancy rate exceeding 55% over time, with mature hospitals targeting occupancy between 55% and 60%. Rainbow’s FY26 annual report showed occupancy declining to 46.3% from 50.5% in FY25, despite inpatient volumes rising 6.2% and outpatient volumes increasing 12.1%. Average revenue per occupied bed increased by 11.5% during that period.

Looking ahead, Rainbow plans to sustain revenue growth above 25% in FY27 and slightly over 20% in FY28. The company is also expanding its offerings in advanced pediatric treatments, including organ transplants, bone marrow transplants, cardiac surgery, and oncology. Pediatrics currently represent about 60-65% of its business, and Rainbow is increasing focus on higher-end services within this segment.

Dalal highlighted the company’s push into quaternary care, including liver, kidney, and bone marrow transplants. The upcoming 325-bed Gurugram hospital will place particular emphasis on pediatric oncology, equipped with advanced diagnostic and treatment facilities.

Fertility services are another area of growth. Rainbow operates in-vitro fertilization (IVF) centers within its hospitals and runs two standalone fertility clinics in Bengaluru. Currently, over 90% of fertility patients come through internal referrals from the obstetrics departments. The company is exploring ways to attract patients directly to its standalone clinics to expand this segment.

International patient inflow is also gaining importance. Rainbow is increasing outreach efforts in West Asia, Africa, and countries in the Commonwealth of Independent States, especially for advanced pediatric procedures. Although international patients currently form a small portion of revenue, their numbers have nearly doubled over the past six months. Dalal stated that while there are no immediate plans to establish hospitals abroad, the focus remains on drawing international patients to Indian facilities.

Rainbow Children’s Medicare’s growth plan reflects broader trends in India’s healthcare sector, where demand for specialized pediatric and maternity services is rising steadily. The company’s internal funding approach, combined with a focus on expanding both capacity and advanced treatment options, positions it well to capitalize on this growing market.